David Cheishvili, PhD

An epigenetics and molecular biology professional with 25+ years of work experience in academic, public and private sectors. Holds PhD in biochemistry and currently serves chief innovation officer at HKG Epitherapeutics (Hong Kong), as an affiliate member (McGill university, Canada).

HKG Epitherapeutics

Pin It on Pinterest

Scroll to Top